Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-25

Clinical Trial Update: Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma [NA]

View source ↗

Summary

Trial investigating pazopanib followed by chemotherapy and surgery for adult soft tissue sarcoma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pazopanib hydrochloride (pazopanib)

Snippet

Sponsor: University of Washington | Conditions: Stage IIA Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma | NA | Status: COMPLETED | Results posted: 2019-04-25